Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.62 USD | +2.93% | -1.48% | -2.21% |
Apr. 04 | Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge | MT |
Apr. 04 | Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge | CI |
Chart calendar Haemonetics Corporation
Upcoming events on Haemonetics Corporation
Past events on Haemonetics Corporation
2024-03-05 07:30 am | Raymond James Institutional Investors Conference |
2024-02-29 08:45 am | Citi Unplugged Medtech and Life Sciences Access Day |
2024-02-08 08:00 am | Q3 2024 Earnings Call |
2024-02-08 06:00 am | Q3 2024 Earnings Release |
2024-01-09 12:45 pm | JPMorgan Healthcare Conference |
2023-11-02 08:00 am | Q2 2024 Earnings Call |
2023-11-02 06:00 am | Q2 2024 Earnings Release |
2023-09-13 | Barrington Virtual Fall Investor Conference |
2023-08-08 08:00 am | Q1 2024 Earnings Call |
2023-08-08 06:00 am | Q1 2024 Earnings Release |
2023-08-04 08:00 am | Annual General Meeting |
2023-05-11 08:00 am | Q4 2023 Earnings Call |
2023-05-11 06:00 am | Q4 2023 Earnings Release |
2023-03-06 08:40 am | Raymond James Institutional Investors Conference |
2023-02-07 08:00 am | Q3 2023 Earnings Call |
2023-02-07 06:00 am | Q3 2023 Earnings Release |
2023-01-10 05:15 pm | JP Morgan Healthcare Conference |
2022-11-07 08:00 am | Interim 2023 Earnings Call |
2022-11-07 06:00 am | Interim 2023 Earnings Release |
2022-09-12 08:45 am | Morgan Stanley Global Healthcare Conference |
Annual results
Fiscal Period | April | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 968 968 -0.09% | 988 996 -0.74% | 870 869 0.18% | 993 986 0.71% | 1 169 1 155 1.19% | 1 295 |
EBITDA Million USD | Released Forecast Spread | 248 257 -3.46% | 307 324 -5.25% | 239 246 -3.05% | 285 268 6.1% | 305 301 1.3% | 358 |
EBIT Million USD | Released Forecast Spread | 165 162 1.65% | 218 221 -1.24% | 155 169 -8.54% | 187 184 1.6% | 218 215 1.57% | 275 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 73,6 83,7 -12.03% | 87,2 95,2 -8.48% | 72,9 121 -39.58% | 63,6 59,0 7.77% | 141 141 0.13% | 170 |
Net income Million USD | Released Forecast Spread | 55,0 52,6 4.67% | 76,5 84,2 -9.14% | 79,5 113 -29.52% | 43,4 42,5 1.94% | 115 106 8.7% | 126 |
EPS USD | Released Forecast Spread | 1,04 1,17 -10.73% | 1,48 1,62 -8.83% | 1,55 2,24 -30.73% | 0,84 0,95 -11.58% | 2,24 2,12 5.49% | 2,50 |
Announcement Date | 07/05/19 | 05/05/20 | 13/05/21 | 10/05/22 | 11/05/23 | - |
Quarterly results
Fiscal Period | April | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 260 265 -2.12% | 265 257 3.07% | 261 249 5% | 297 269 10.5% | 305 300 1.61% | 304 291 4.69% | 311 293 6.37% | 318 313 1.62% | 336 321 4.82% | 329 | 329 | 340 | 357 | 340 |
EBITDA Million USD | Released Forecast Spread | 71,0 65,9 7.79% | 71,4 62,0 15.15% | 64,3 56,3 14.06% | 67,7 69,8 -2.99% | 82,0 80,3 2.1% | 76,9 74,1 3.75% | 92,8 72,2 28.58% | 90,8 83,6 8.65% | 96,9 81,7 18.62% | 84,9 | 96,4 | 99,3 | 102 | 97,1 |
EBIT Million USD | Released Forecast Spread | 58,8 52,3 12.44% | 46,6 43,8 6.27% | 44,9 38,6 16.3% | 60,6 48,9 23.89% | 59,0 60,7 -2.72% | 53,9 51,2 5.36% | 70,2 54,6 28.7% | 68,3 64,4 6.08% | 73,4 67,3 9.09% | 63,5 | 73,5 | 76,4 | 81,1 | 76,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 31,4 14,2 121.15% | 15,3 10,7 42.7% | 25,5 8,34 205.83% | 41,1 30,9 33.05% | 42,2 38,1 10.81% | 32,6 32,4 0.55% | 51,6 29,9 72.78% | 32,8 47,4 -30.78% | 44,0 47,2 -6.73% | 41,8 | 52,4 | 55,8 | 57,9 | 53,8 |
Net income Million USD | Released Forecast Spread | 23,2 14,9 55.5% | 9,74 8,92 9.27% | 19,9 6,92 187.28% | 33,2 18,7 77.19% | 32,9 27,9 18.24% | 29,4 20,2 45.79% | 41,0 21,0 95.48% | 24,9 31,4 -20.7% | 31,2 31,7 -1.52% | 28,6 | 35,6 | 38,9 | 42,8 | 41,0 |
EPS USD | Released Forecast Spread | 0,45 0,39 15.38% | 0,19 0,30 -35.59% | 0,38 0,22 72.73% | 0,64 0,41 57.38% | 0,64 0,57 12.28% | 0,57 0,45 26.67% | 0,80 0,52 54.84% | 0,48 0,69 -30.43% | 0,61 0,70 -12.86% | 0,60 | 0,76 | 0,81 | 0,90 | 0,84 |
Announcement Date | 08/02/22 | 10/05/22 | 10/08/22 | 07/11/22 | 07/02/23 | 11/05/23 | 08/08/23 | 02/11/23 | 08/02/24 | - | - | - | - | - |
2024-04-23 | SHANGHAI KINETIC MEDICAL CO., LTD: Q1 2024 Earnings Release |
2024-04-24 01:30 am | XVIVO PERFUSION AB: Q1 2024 Earnings Release |
2024-04-24 04:00 pm | ALIGN TECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-04-24 04:05 pm | CONMED CORPORATION: Q1 2024 Earnings Release |
2024-04-24 | DEXCOM, INC.: Q1 2024 Earnings Release |
2024-04-25 06:00 am | WEST PHARMACEUTICAL SERVICES, INC.: Q1 2024 Earnings Release |
2024-04-25 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
2024-04-25 | SINOCARE INC.: Q4 2023 Earnings Release |
2024-04-25 | SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.: Q1 2024 Earnings Release (Projected) |
Past sector events for Haemonetics Corporation
2024-04-21 | SHANGHAI KINETIC MEDICAL CO., LTD: Q4 2023 Earnings Release |
2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
2024-04-19 | LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
2024-04-18 | WELL LEAD MEDICAL CO., LTD.: Q4 2023 Earnings Release |
2024-04-18 08:00 am | ARJO AB: Q1 2024 Earnings Release |
2024-04-18 01:02 am | SARTORIUS STEDIM BIOTECH: Q1 2024 Earnings Release |
2024-04-17 07:30 am | ABBOTT LABORATORIES: Q1 2024 Earnings Release |
2024-04-16 | JIANGXI SANXIN MEDTEC CO.,LTD.: Q1 2024 Earnings Release |
2024-04-15 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q4 2023 Earnings Release |
2024-04-11 01:00 am | GERRESHEIMER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HAE Stock
- Calendar Haemonetics Corporation